Organon & Co | OGN - Ebit

Aktienkurs
6.34
Täglich Wechseln
-0.01 -0.16%
Monatlich
-12.91%
Jährlich
-59.41%
Q1 Prognose
6.16




Ebit Veränderung Datum
Bristol-Myers Squibb USD 3.47B 567M 2025-12
Celltrion KRW 301.04B 58.57B 2025-09
Cspc Pharmaceutical CNY 1.22B 60.54M 2025-09
Deva Holding AS TRY 820.88M 192.13M 2023-09
Dianthus Therapeutics USD -40.29M 5.36M 2025-09
Divis Laboratories Ltd INR 7.72B 30M 2025-12
Gilead Sciences USD 2.96B 551M 2025-12
Glaxosmithkline GBP 3.76B 1.69B 2025-09
Kangmei Pharma CNY -26.7M 43.13M 2025-09
Knight Therapeutics CAD 2.94M 2.4M 2025-09
Malin Corporation EUR -1.1M 300K 2024-12
Medical Developments International AUD -36K 12.96M 2025-12
Merck USD 6.24B 1.32B 2025-12
Neuren Pharmaceuticals AUD 17.01M 154.09M 2025-12
Novartis USD 4.48B 343M 2025-09
Organigram Holdings CAD -28.05M 25.94M 2025-09
Organon & Co USD 388M 28M 2025-09
Ovoca Bio EUR -5.65M 3.45M 2022-06
Pharma Mar EUR 43.61M 47.57M 2025-12
Qiagen NV USD 121.88M 19.18M 2025-12
Sartorius EUR 150.1M 11.7M 2025-09
Sino Biopharmaceutical CNY 5.18B 3.32B 2025-06
Tilray USD -20.01M 9.34M 2025-09